A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
HYFIX.AI Launches New RTK Rovers With Quectel LC29H GNSS Module on CrowdSupply
Lucid shares drop on flat second-quarter deliveries, production drop
Costco, Nike, Micron, Carnival, and More Stocks to Watch This Week
David Hockney unveils Christmas display to bring ‘joy and hope’ to Londoners
Experts have figured out the science behind optical illusions
AI Is the Stock Market’s ‘New Growth Thing,’ Citi’s Chronert Says
What to watch this weekend: ‘Succession’ finale, John Wick, Matchbox Twenty, 'American Born Chinese'
Scientists prove animal named after Attenborough is not extinct after all